HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Upward trends in new, rifampicin-resistant and concurrent extrapulmonary tuberculosis cases in northern Guizhou Province of China.

Abstract
Similar to global trends, the incidence rate of tuberculosis (TB) in China declined from 2000 to 2018. In this study, we aimed to evaluate TB trends in northern Guizhou Province and identify risk factors associated with rifampicin-resistant (RR) and concurrent extrapulmonary TB (EPTB). We analyzed data of TB patients hospitalized in Affiliated Hospital of Zunyi Medical University from 2011 to 2018, and assessed correlations between demographic characteristics of patients and RR-TB as well as concurrent EPTB. Our results showed that numbers of new, retreated, RR-TB and concurrent EPTB cases increased gradually from 2011 to 2018. Retreated patients had the highest odds of RR-TB but a lower likelihood of concurrent EPTB compared to new patients. Patients between 21 and 40 years of age had a higher likelihood of RR-TB compared to those 20 years and younger. Female patients and patients from Bijie city as well as the Miao ethnic minority had higher odds of concurrent EPTB. In summary, our data demonstrate upward trends in new, rifampicin-resistant and concurrent extrapulmonary TB cases in northern Guizhou Province of China, which should not be overlooked especially during and post the COVID-19 pandemic because TB is a greater long-term global health threat than COVID-19.
AuthorsLing Chen, Xuefeng Fu, Peng Tian, Qing Li, Dan Lei, Zhangli Peng, Quanxian Liu, Nana Li, Jianyong Zhang, Peng Xu, Hong Zhang
JournalScientific reports (Sci Rep) Vol. 11 Issue 1 Pg. 18023 (09 09 2021) ISSN: 2045-2322 [Electronic] England
PMID34504296 (Publication Type: Journal Article, Observational Study, Research Support, Non-U.S. Gov't)
Copyright© 2021. The Author(s).
Chemical References
  • Antibiotics, Antitubercular
  • Rifampin
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibiotics, Antitubercular (therapeutic use)
  • Child
  • China (epidemiology)
  • Drug Resistance, Multiple, Bacterial (physiology)
  • Expert Systems
  • Female
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Mycobacterium tuberculosis (drug effects, genetics, isolation & purification)
  • Retrospective Studies
  • Rifampin (therapeutic use)
  • Risk Factors
  • Tuberculosis, Pulmonary (drug therapy, epidemiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: